Transamerica Financial Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Transamerica Financial Advisors’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1	Closed	-$1K	–	528
2016 Q1	$1K	Hold	1	–	–	﹤0.01%	696
2015 Q4	$1K	Hold	1	–	–	﹤0.01%	755
2015 Q3	$1K	Hold	1	–	–	﹤0.01%	752
2015 Q2	$1K	Hold	1	–	–	﹤0.01%	812
2015 Q1	$1K	Hold	1	–	–	﹤0.01%	810
2014 Q4	$1K	Hold	1	–	–	﹤0.01%	655
2014 Q3	$1K	Hold	1	–	–	﹤0.01%	614
2014 Q2	$1K	Hold	1	–	–	﹤0.01%	622
2014 Q1	$1K	Hold	1	–	–	﹤0.01%	587
2013 Q4	$1K	Hold	1	–	–	﹤0.01%	571
2013 Q3	$1K	Hold	1	–	–	﹤0.01%	568
2013 Q2	$1K	Buy	+1	New	+$18	﹤0.01%	543

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Transamerica Financial Advisors's HQL Position: Q2 2016 in Review

Transamerica Financial Advisors sold out of abrdn Life Sciences Investors (HQL) in Q2 2016, closing a stake of 1 share — an estimated $1K sold.

Transamerica Financial Advisors first reported a position in HQL in Q2 2013 and held it in 12 quarters. The position peaked at $1K in Q1 2016. 50 funds tracked by Wall St. Rank hold HQL as of Q2 2016.

Transamerica Financial Advisors reported no remaining abrdn Life Sciences Investors position as of Q2 2016 after selling out during the quarter.
Transamerica Financial Advisors sold 1 abrdn Life Sciences Investors share in Q2 2016, an estimated $1K.
Transamerica Financial Advisors first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 12 quarters.
Transamerica Financial Advisors's abrdn Life Sciences Investors position peaked at $1K in Q1 2016.
50 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2016.

Based on Transamerica Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.